Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-21

FDA Approved: DENAVIR — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Denavir (penciclovir) submitted by Mylan Pharmaceuticals Inc., related to its approved topical antiviral for recurre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DENAVIR (PENCICLOVIR)

Snippet

SUPPL AP for DENAVIR (PENCICLOVIR)